Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Legal-Education Plus Trauma-informed Therapy to Improve Community Acceptance and Reintegration of Repentant Terrorists in Nigeria (LETiT)

25 mai 2022 mis à jour par: Dr Dung Jidong, PhD, Nottingham Trent University

Legal-Education Plus Trauma-informed Therapy to Improve Community Acceptance and Reintegration of Repentant Terrorists in Nigeria: A Pilot Randomised Controlled Trial

Terrorism is an issue of global concern, and reintegrating repentant terrorists, including their families, has often proved challenging considering the damages done by the terrorist group. Despite Boko Haram atrocities in Nigeria, the focus seems directed toward the repentant terrorists with limited attention to the communities, the trauma they suffered, and their involvement in the design of reintegration programmes. There is also limited community awareness of legal support channels to foster positive reintegration (Ike et al., 2021). The implication is that it risks undermining the social context that informs successful reintegration, improves acceptance, and reduces reoffending. However, there appears to be limited research on this important policy problem in Nigeria. Our study proposes to fill this gap by contributing to the research initiative through a novel cross-disciplinary intervention drawing on law and psychology entitled Legal Education plus Trauma-informed Therapy (LETiT) to improve community acceptance and reintegration of repentant terrorists in Nigeria.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Anticipé)

150

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

  • Nom: Tarela Ike, PhD
  • Numéro de téléphone: +44 1642 34 2316
  • E-mail: t.ike@tees.ac.uk

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 85 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • ages 18 - 85 years
  • able to give consent
  • able to understand and speak English
  • score a minimum of 5 on Trauma Screening Questionnaire
  • residents of designated communities of intervention (Adamawa, Maiduguri, and Plateau states)
  • available for the study and follow up at 3- and 6-months post-intervention

Exclusion Criteria:

  • less than 18 or above 85 years
  • unable to give consent
  • clinically diagnosed with severe PTSD/suicidal ideations or undergoing treatment
  • temporary or non-residents who are unlikely to be available for follow up

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: LETiT

The LETiT intervention will cover (a) Legal education with numerous aspects relating to human rights, access to legal support and tackling traumatic experiences.

(b) The Trauma-informed Therapy component will involve addressing trauma, dispelling negative thoughts and building more positive thinking.

It is worth adding that the LETiT intervention has undergone standardisation of procedure by adopting a coherent manual (e.g., the Legal Education plus Trauma-informed Therapy manual) specifically designed for the proposed intervention. For example, the legal education contents are collated from extant laws, including the 1999 Constitution of the Federal Republic of Nigeria.

Group-1: Experimental (n=75 participants) will receive the LETiT which consists of a total of 12-group integrated sessions lasting approximately 60-90 minutes per session every week with 20-25 persons per sub-group.
Comparateur actif: Intervention As Usual (IAU)

The Intervention As Usual (IAU) component of the proposed project is designed through a systematic collation of numerous government and non-governmental organisations' support information (e.g., news information and basic re-orientation of community members affected by terrorism). Thus, the IAU group will receive the government intervention involving media messages from the National Orientation Agency devoid of legal education or trauma-informed therapy.

The training materials are organised to address key aspects of care such as (a) acknowledgement of the severity of lived experiences (b) reflection of current help received from the government and humanitarian services (c) essential aspects of self-care and caring for the vulnerable family and community members (d) inspiration for the future etc.

Group-2: Controlled (n=75 participants) will receive the IAU which consists of a total of 12-group integrated sessions lasting approximately 60-90 minutes per session every week with 20-25 persons per sub-group.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Trauma Screening Questionnaire
Délai: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in traumatic experience is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Adaptive Stress Index
Délai: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in stress is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Patient Health Questionnaire
Délai: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in depression is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Generalised Anxiety Disorder Scale
Délai: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in anxiety is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Legal-Education Awareness Scale
Délai: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in awareness of human right is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Attitude Towards Repentant Terrorists and their Reintegration Scale
Délai: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in of attitude towards repentant terrorists is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
brief Verona Service Satisfaction Scale
Délai: Change is being assessed at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in service satisfaction is being assessed
Change is being assessed at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Dung Jidong, PhD, Nottingham Trent University, UK

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Anticipé)

20 juin 2022

Achèvement primaire (Anticipé)

19 juin 2023

Achèvement de l'étude (Anticipé)

30 septembre 2023

Dates d'inscription aux études

Première soumission

25 mai 2022

Première soumission répondant aux critères de contrôle qualité

25 mai 2022

Première publication (Réel)

31 mai 2022

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

31 mai 2022

Dernière mise à jour soumise répondant aux critères de contrôle qualité

25 mai 2022

Dernière vérification

1 mai 2022

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 0000-0001-5034-0335d

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner